Mankind Pharma Ltd. - Research Center

---

Results

• Quarterly
• Half yearly
• Annual

Statement

• Balance sheet
• P&L
• Cash flow

More

• Share holding
• Capital structures
• Ratio

Mar ' 24	Mar ' 23	Mar ' 22	Mar ' 21	Mar ' 20

Sales

9,264.81

8,127.15

7,486.22

5,529.60

4,794.41

Operating profit

2,325.10

1,697.38

1,838.07

1,378.29

1,243.46

Interest

14.57

27.75

47.12

7.98

10.62

Gross profit

2,577.17

1,832.42

1,994.76

1,518.39

1,326.69

EPS (Rs)

45.52

31.16

34.68

27.07

23.92

Other income

266.64

162.78

203.81

148.08

93.85

Stock adjustment

-25.36

267.89

-365.27

-254.25

-44.51

Raw material

861.74

711.05

772.59

494.53

434.87

Power and fuel

-

-

-

-

-

Employee expenses

1,982.10

1,701.38

1,462.76

1,106.14

991.47

Excise

-

-

-

-

-

Admin and selling expenses

-

-

-

-

-

Research and development expenses

-

-

-

-

-

Expenses capitalised

-

-

-

-

-

Other expenses

4,121.22

3,749.46

3,778.07

2,804.89

2,169.12

Provisions made

-

-

-

-

-

Depreciation

317.61

269.58

123.33

78.19

61.77

Taxation

436.16

314.58

482.01

355.83

306.70

Net profit / loss

1,823.41

1,248.26

1,389.42

1,084.37

958.23

Extra ordinary item

-

-

-

-

-

Prior year adjustments

-

-

-

-

-

Equity capital

40.06

40.06

40.06

40.06

40.06

Equity dividend rate

-

-

-

-

-

Agg.of non-prom. shares (Lacs)

-

-

-

-

-

Agg.of non promotoholding (%)

-

-

-

-

-

OPM (%)

25.10

20.89

24.55

24.93

25.94

GPM (%)

27.04

22.10

25.94

26.74

27.14

NPM (%)

19.13

15.06

18.07

19.10

19.60